Preparation of vaccines using a photosensitizer and light
AssigneeGambro AB
InventorRaymond P. Goodrich
Life of this patent
Estimating the term…
Abstract
Methods are provided for treating a vaccine containing infectious particles which may be viral, bacterial, and/or cellular in nature. Preferred methods include the steps of adding an effective, non-toxic amount of an endogenous photosensitizer to the fluid and exposing the fluid to photoradiation sufficient to inactivate the infectious particles but not enough to damage the antigenic characteristics of the infectious particles.
Claims11
A method of making a vaccine from one or more infectious particles comprising:
- inactivating the infectious particles by adding an effective amount of an endogengous isoalloxazine photosensitizer to the one or more infectious particles and exposing the particles to light of a sufficient wavelength to prevent replication of the infectious particles but not substantially destroy the antigenic determinants of the particles;
- and
- suspending the inactivated particles in a suspension solution to create a vaccine.
A method of making a vaccine containing a live virus comprising the steps of:
- adding an effective amount of an endogenous isoalloxazine photosensitizer to the virus and exposing the virus to light of a sufficient wavelength to prevent replication of the live virus but not substantially destroy the antigenic determinants of the virus to create an inactivated live virus;
- and
- suspending the inactivated live virus in a suspension solution to create a vaccine.
A method for inactivating infectious particles without substantially degrading the antigenic characteristics of the particles, comprising the steps of:
- exposing the infectious particles to an inactivation fluid containing at least an endogenous isoalloxazine photosensitizer in an amount sufficient to render the particles substantially non-infectious;
- and
- exposing the infectious particles and inactivation fluid to light of a sufficient wavelength and for a sufficient time to render the particles substantially non-infectious but less than that which would result in degradation of the antigenic characteristics of the infectious particles.
Dependencies are inferred from the claim text.